{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:57:55Z","timestamp":1789444675730,"version":"build-2803163510"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Center for Human Reproduction","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"Foundation for Reproductive Medicine","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10815-017-0977-4","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T01:17:22Z","timestamp":1498094242000},"page":"1105-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Potential therapeutic applications of human anti-M\u00fcllerian hormone (AMH) analogues in reproductive medicine"],"prefix":"10.1007","volume":"34","author":[{"given":"Vitaly A.","family":"Kushnir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritro","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"key":"977_CR1","volume-title":"Antimullerian hormone: biology, role in ovarian function and clinical significance","author":"DB Seifer","year":"2016","unstructured":"Seifer DB, Tal R. Antimullerian hormone: biology, role in ovarian function and clinical significance. New York: Nova Science Publishers; 2016."},{"issue":"9","key":"977_CR2","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1210\/en.2001-211352","volume":"143","author":"VM Laurich","year":"2002","unstructured":"Laurich VM, Trbovich AM, O\u2019Neill FH, Houk CP, Sluss PM, Payne AH, et al. M\u00fcllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p 450 17alpha-hydroxylase\/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation. Endocrinology. 2002;143(9):3351\u201360.","journal-title":"Endocrinology"},{"issue":"4","key":"977_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dmi014","volume":"11","author":"N Josso","year":"2005","unstructured":"Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent M\u00fcllerian duct syndrome. Hum Reprod Update. 2005;11(4):351\u20136.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"977_CR4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","volume":"143","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143(3):1076\u201384.","journal-title":"Endocrinology"},{"issue":"3","key":"977_CR5","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1210\/endo-123-3-1652","volume":"123","author":"S Ueno","year":"1988","unstructured":"Ueno S, Manganaro TF, Donahoe PK. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology. 1988;123(3):1652\u20139.","journal-title":"Endocrinology"},{"issue":"3","key":"977_CR6","first-page":"911","volume":"75","author":"JH Kim","year":"1992","unstructured":"Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, et al. The inhibitory effects of m\u00fcllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. J Clin Endocrinol Metab. 1992;75(3):911\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"977_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13048-014-0113-3","volume":"7","author":"A Kedem","year":"2014","unstructured":"Kedem A, Yung Y, Yerushalmi GM, Haas J, Maman E, Hanochi M, et al. Anti M\u00fcllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res. 2014;7:113.","journal-title":"J Ovarian Res."},{"issue":"7","key":"977_CR8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/09513590.2013.798279","volume":"29","author":"A Kedem","year":"2013","unstructured":"Kedem A, Hourvitz A, Yung Y, Shalev L, Yerushalmi GM, Kanety H, et al. Anti-M\u00fcllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. Gynecol Endocrinol. 2013;29(7):651\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"977_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.221599298","volume":"99","author":"DL Segev","year":"2002","unstructured":"Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, et al. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A. 2002;99(1):239\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"977_CR10","doi-asserted-by":"crossref","first-page":"26799","DOI":"10.1074\/jbc.M103092200","volume":"276","author":"DL Segev","year":"2001","unstructured":"Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, MacLaughlin DT, et al. Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo. J Biol Chem. 2001;276(29):26799\u2013806.","journal-title":"J Biol Chem"},{"issue":"4","key":"977_CR11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2008.01.028","volume":"91","author":"J Wang","year":"2009","unstructured":"Wang J, Dicken C, Lustbader JW, Tortoriello DV. Evidence for a M\u00fcllerian-inhibiting substance autocrine\/paracrine system in adult human endometrium. Fertil Steril. 2009;91(4):1195\u2013203.","journal-title":"Fertil Steril"},{"key":"977_CR12","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7:10055.","journal-title":"Nat Commun"},{"key":"977_CR13","unstructured":"AMHR2 anti-Mullerian hormone receptor type 2 [Homo sapiens (human)] [Internet]. [cited 2016 Mar 29]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/269"},{"issue":"3","key":"977_CR14","first-page":"711","volume":"76","author":"DB Seifer","year":"1993","unstructured":"Seifer DB, MacLaughlin DT, Penzias AS, Behrman HR, Asmundson L, Donahoe PK, et al. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid m\u00fcllerian-inhibiting substance and androgen content. J Clin Endocrinol Metab. 1993;76(3):711\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"977_CR15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77(3):468\u201371.","journal-title":"Fertil Steril"},{"issue":"8","key":"977_CR16","first-page":"2696","volume":"84","author":"J Young","year":"1999","unstructured":"Young J, Rey R, Couzinet B, Chanson P, Josso N, Schaison G. Antim\u00fcllerian hormone in patients with hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1999;84(8):2696\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"977_CR17","doi-asserted-by":"crossref","unstructured":"Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM, Massin N, Maione L, Beau I, et al. Anti-Mullerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism\/Kallmann syndrome. Effects of recombinant human FSH. J Clin Endocrinol Metab. 2017","DOI":"10.1210\/jc.2016-3799"},{"issue":"6","key":"977_CR18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.2006.02533.x","volume":"64","author":"A Marca La","year":"2006","unstructured":"La Marca A, Volpe A. Anti-M\u00fcllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64(6):603\u201310.","journal-title":"Clin Endocrinol"},{"issue":"7","key":"977_CR19","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","volume":"6","author":"TW Kelsey","year":"2011","unstructured":"Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. A validated model of serum anti-m\u00fcllerian hormone from conception to menopause. PLoS One. 2011;6(7):e22024.","journal-title":"PLoS One"},{"issue":"1","key":"977_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119\u201330.e3.","journal-title":"Fertil Steril"},{"issue":"1","key":"977_CR21","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","volume":"211","author":"R Tal","year":"2014","unstructured":"Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B. Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol. 2014;211(1):59.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"977_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12020-016-1068-5","volume":"54","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Darmon SK, Kushnir VA, Weghofer A, Wang Q, Zhang L, et al. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields. Endocrine. 2016;54(2):476\u201383.","journal-title":"Endocrine"},{"key":"977_CR23","doi-asserted-by":"crossref","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user\u2019s guide. Am J Obstet Gynecol. 2017;21.","DOI":"10.1016\/j.ajog.2017.02.027"},{"issue":"2","key":"977_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","volume":"107","author":"A Nyboe Andersen","year":"2017","unstructured":"Nyboe Andersen A, Nelson SM, Fauser BC, Garc\u00eda-Velasco JA, Klein BM, Arce JC, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017;107(2):387\u2013396.e4.","journal-title":"Fertil Steril"},{"issue":"8","key":"977_CR25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0046-8177(98)90454-3","volume":"29","author":"X Matias-Guiu","year":"1998","unstructured":"Matias-Guiu X, Pons C, Prat J. M\u00fcllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol. 1998;29(8):840\u20135.","journal-title":"Hum Pathol"},{"issue":"10","key":"977_CR26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/hupa.2000.18498","volume":"31","author":"R Rey","year":"2000","unstructured":"Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, et al. Anti-M\u00fcllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol. 2000;31(10):1202\u20138.","journal-title":"Hum Pathol"},{"issue":"21","key":"977_CR27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jnci\/djp331","volume":"101","author":"JF Dorgan","year":"2009","unstructured":"Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, et al. Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst. 2009;101(21):1501\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"977_CR28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1940-6207.CAPR-14-0377","volume":"8","author":"HB Nichols","year":"2015","unstructured":"Nichols HB, Baird DD, Stanczyk FZ, Steiner AZ, Troester MA, Whitworth KW, et al. Anti-M\u00fcllerian hormone concentrations in premenopausal women and breast cancer risk. Cancer Prev Res (Phila). 2015;8(6):528\u201334.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"977_CR29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1055-9965.EPI-15-1240","volume":"25","author":"AH Eliassen","year":"2016","unstructured":"Eliassen AH, Zeleniuch-Jacquotte A, Rosner B, Hankinson SE. Plasma anti-M\u00fcllerian hormone concentrations and risk of breast cancer among premenopausal women in the nurses\u2019 health studies. Cancer Epidemiol Biomark Prev. 2016;25(5):854\u201360.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"977_CR30","first-page":"657","volume":"22","author":"J Teixeira","year":"2001","unstructured":"Teixeira J, Maheswaran S, Donahoe PK. M\u00fcllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev. 2001;22(5):657\u201374.","journal-title":"Endocr Rev"},{"issue":"3","key":"977_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/fon.09.172","volume":"6","author":"DT MacLaughlin","year":"2010","unstructured":"MacLaughlin DT, Donahoe PK. M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone: a potential therapeutic agent for human ovarian and other cancers. Future Oncol. 2010;6(3):391\u2013405.","journal-title":"Future Oncol"},{"issue":"5","key":"977_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5468\/ogs.2014.57.5.343","volume":"57","author":"JH Kim","year":"2014","unstructured":"Kim JH, MacLaughlin DT, Donahoe PK. M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone: a novel treatment for gynecologic tumors. Obstet Gynecol Sci. 2014;57(5):343\u201357.","journal-title":"Obstet Gynecol Sci"},{"issue":"12","key":"977_CR33","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"AL Durlinger","year":"1999","unstructured":"Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary. Endocrinology. 1999;140(12):5789\u201396.","journal-title":"Endocrinology"},{"issue":"9","key":"977_CR34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","volume":"21","author":"IB Carlsson","year":"2006","unstructured":"Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-M\u00fcllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod. 2006;21(9):2223\u20137.","journal-title":"Hum Reprod"},{"key":"977_CR35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2016.05.019","volume":"433","author":"E Hayes","year":"2016","unstructured":"Hayes E, Kushnir V, Ma X, Biswas A, Prizant H, Gleicher N, et al. Intra-cellular mechanism of anti-M\u00fcllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016;433:56\u201365.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"977_CR36","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","volume":"114","author":"M Kano","year":"2017","unstructured":"Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, et al. AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A. 2017;114(9):E1688\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"977_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jtbi.2013.02.007","volume":"326","author":"A Margolskee","year":"2013","unstructured":"Margolskee A, Selgrade JF. A lifelong model for the female reproductive cycle with an antim\u00fcllerian hormone treatment to delay menopause. J Theor Biol. 2013;326:21\u201335.","journal-title":"J Theor Biol"},{"issue":"9","key":"977_CR38","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","volume":"19","author":"AG Mulders","year":"2004","unstructured":"Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-M\u00fcllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod. 2004;19(9):2036\u201342.","journal-title":"Hum Reprod"},{"issue":"7","key":"977_CR39","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","volume":"25","author":"FR Tehrani","year":"2010","unstructured":"Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod. 2010;25(7):1775\u201381.","journal-title":"Hum Reprod"},{"issue":"185","key":"977_CR40","doi-asserted-by":"crossref","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62.","journal-title":"Sci Transl Med"},{"issue":"12","key":"977_CR41","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","volume":"114","author":"KN Goldman","year":"2017","unstructured":"Goldman KN, Chenette D, Arju R, Duncan FE, Keefe DL, Grifo JA, et al. mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proc Natl Acad Sci U S A. 2017;114(12):3186\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"977_CR42","unstructured":"2014 Fertility Clinic Success Rates | Assisted Reproductive Technology (ART) Report | Reproductive Health | CDC [Internet]. [cited 2016 Dec 7]. Available from: https:\/\/www.cdc.gov\/art\/reports\/42.\/fertility-clinic.html"},{"key":"977_CR43","doi-asserted-by":"crossref","first-page":"193371911769713","DOI":"10.1177\/1933719117697130","volume":"1","author":"VA Kushnir","year":"2017","unstructured":"Kushnir VA, Safdie M, Darmon SK, Albertini DF, Barad DH, Gleicher N. Age-specific IVF outcomes in infertile women with baseline FSH levels \u226520 mIU\/mL. Reprod Sci. 2017;1:1933719117697130.","journal-title":"Reprod Sci"},{"key":"977_CR44","doi-asserted-by":"crossref","unstructured":"Gleicher N, Kushnir VA, Sen A, Darmon SK, Weghofer A, Wu Y, et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med. 2016;14(1).","DOI":"10.1186\/s12967-016-0924-7"},{"key":"977_CR45","doi-asserted-by":"crossref","unstructured":"Gleicher N, Vega MV, Darmon SK, Weghofer A, Wu YG, Wang Q, et al. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transfered. Fertil Steril. 2015.","DOI":"10.1016\/j.fertnstert.2015.08.023"},{"issue":"7","key":"977_CR46","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.fertnstert.2016.09.013","volume":"106","author":"J Nassar","year":"2016","unstructured":"Nassar J, Tadros T, Adda-Herzog E, Ayoubi JM, Fanchin R. Steroid hormone pretreatments in assisted reproductive technology. Fertil Steril. 2016;106(7):1608\u201314.","journal-title":"Fertil Steril"},{"issue":"6","key":"977_CR47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","volume":"29","author":"Y Kuang","year":"2014","unstructured":"Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol). Reprod BioMed Online. 2014;29(6):684\u201391.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"977_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/JOE-15-0246","volume":"226","author":"YG Wu","year":"2015","unstructured":"Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167\u201380.","journal-title":"J Endocrinol"},{"issue":"1","key":"977_CR49","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1530\/JOE-16-0105","volume":"230","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Kushnir VA, Albertini DF, Barad DH. Improvements in IVF in women of advanced age. J Endocrinol. 2016;230(1):F1\u20136.","journal-title":"J Endocrinol"},{"issue":"10","key":"977_CR50","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/en.2013-1679","volume":"154","author":"N Gleicher","year":"2013","unstructured":"Gleicher N, Kushnir VA, Barad DH. Therapeutic interventions into early stages of follicle maturation: a new treatment paradigm after over 50 years of modern infertility therapy. Endocrinology. 2013;154(10):3498\u2013501.","journal-title":"Endocrinology"},{"issue":"5","key":"977_CR51","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.fertnstert.2014.01.052","volume":"101","author":"P Carrarelli","year":"2014","unstructured":"Carrarelli P, Rocha AL, Belmonte G, Zupi E, Abr\u00e3o MS, Arcuri F, et al. Increased expression of antim\u00fcllerian hormone and its receptor in endometriosis. Fertil Steril. 2014;101(5):1353\u20138.","journal-title":"Fertil Steril"},{"key":"977_CR52","doi-asserted-by":"crossref","first-page":"361489","DOI":"10.1155\/2013\/361489","volume":"2013","author":"MA Borahay","year":"2013","unstructured":"Borahay MA, Lu F, Ozpolat B, Tekedereli I, Gurates B, Karipcin S, et al. Mullerian inhibiting substance suppresses proliferation and induces apoptosis and autophagy in endometriosis cells in vitro. ISRN Obstet Gynecol. 2013;2013:361489.","journal-title":"ISRN Obstet Gynecol"},{"issue":"9","key":"977_CR53","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2012-1538","volume":"97","author":"J Namkung","year":"2012","unstructured":"Namkung J, Song JY, Jo HH, Kim MR, Lew YO, Donahoe PK, et al. Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis. J Clin Endocrinol Metab. 2012;97(9):3224\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"977_CR54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-9966-33-46","volume":"33","author":"PG Signorile","year":"2014","unstructured":"Signorile PG, Petraglia F, Baldi A. Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells. J Exp Clin Cancer Res. 2014;33:46.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"977_CR55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","volume":"82","author":"A Marca La","year":"2004","unstructured":"La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82(4):970\u20132.","journal-title":"Fertil Steril"},{"issue":"2","key":"977_CR56","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296(2):E238\u201343.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"977_CR57","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24(11):2917\u201323.","journal-title":"Hum Reprod"},{"issue":"1","key":"977_CR58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","volume":"96","author":"YH Lin","year":"2011","unstructured":"Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, Hsu MI. Antim\u00fcllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230\u20135.","journal-title":"Fertil Steril"},{"issue":"6","key":"977_CR59","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/jc.2013-3781","volume":"99","author":"LA Sjaarda","year":"2014","unstructured":"Sjaarda LA, Mumford SL, Kissell K, Schliep KC, Hammoud AO, Perkins NJ, et al. Increased androgen, anti-M\u00fcllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype? J Clin Endocrinol Metab. 2014;99(6):2208\u201316.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"977_CR60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13048-015-0175-x","volume":"8","author":"VA Kushnir","year":"2015","unstructured":"Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome. J Ovarian Res. 2015;8(1):45.","journal-title":"J Ovarian Res"},{"issue":"3","key":"977_CR61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):941\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"977_CR62","doi-asserted-by":"crossref","unstructured":"Albertini DF. The mammalian oocyte. In: Plant TM, Zeleznik AJ, editors. Knobil and Neill\u2019s Physiology of reproduction. 4, revised. Academic Press; 2014.","DOI":"10.1016\/B978-0-12-397175-3.00002-8"},{"key":"977_CR63","unstructured":"Folliculogenesis EduGraphic | Ansh Labs [Internet]. [cited 2017 Apr 26]. Available from: http:\/\/www.anshlabs.com\/folliculogenesis\/"},{"key":"977_CR64","doi-asserted-by":"crossref","unstructured":"Gleicher N, Kushnir VA, Darmon SK, Wang Q, Zhang L, Albertini DF, et al. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. J Steroid Biochem Mol Biol. 2016.","DOI":"10.1016\/j.jsbmb.2016.12.004"},{"issue":"4","key":"977_CR65","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/humrep\/det033","volume":"28","author":"N Gleicher","year":"2013","unstructured":"Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, et al. Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod. 2013;28(4):1084\u201391.","journal-title":"Hum Reprod"},{"key":"977_CR66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-016-0158-9","volume":"14","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Kushnir VA, Weghofer A, Barad DH. The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod Biol Endocrinol. 2016;14:23.","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"977_CR67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrendo.2015.64","volume":"11","author":"A Shohat-Tal","year":"2015","unstructured":"Shohat-Tal A, Sen A, Barad DH, Kushnir V, Gleicher N. Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol. 2015;11(7):429\u201341.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"977_CR68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrendo.2013.212","volume":"10","author":"A Sen","year":"2014","unstructured":"Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014;10(1):37\u201350.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"977_CR69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1043-2760(02)00602-1","volume":"13","author":"CE Keegan","year":"2002","unstructured":"Keegan CE, Hammer GD. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol Metab. 2002;13(5):200\u20138.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"977_CR70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1933719115594021","volume":"23","author":"HS Kong","year":"2016","unstructured":"Kong HS, Kim SK, Lee J, Youm HW, Lee JR, Suh CS, et al. Effect of exogenous anti-M\u00fcllerian hormone treatment on cryopreserved and transplanted mouse ovaries. Reprod Sci. 2016;23(1):51\u201360.","journal-title":"Reprod Sci"},{"issue":"11","key":"977_CR71","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/humrep\/dev210","volume":"30","author":"D Meirow","year":"2015","unstructured":"Meirow D, Roness H, Kristensen SG, Andersen CY. Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation. Hum Reprod. 2015;30(11):2453\u20136.","journal-title":"Hum Reprod"},{"issue":"43","key":"977_CR72","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1312830110","volume":"110","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013;110(43):17474\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"977_CR73","doi-asserted-by":"crossref","first-page":"e0127786","DOI":"10.1371\/journal.pone.0127786","volume":"10","author":"E Novella-Maestre","year":"2015","unstructured":"Novella-Maestre E, Herraiz S, Rodr\u00edguez-Iglesias B, D\u00edaz-Garc\u00eda C, Pellicer A. Short-term PTEN inhibition improves in vitro activation of primordial follicles, preserves follicular viability, and restores AMH levels in cryopreserved ovarian tissue from cancer patients. PLoS One. 2015;10(5):e0127786.","journal-title":"PLoS One"},{"issue":"10\u201312","key":"977_CR74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1387\/ijdb.130001et","volume":"56","author":"EE Telfer","year":"2012","unstructured":"Telfer EE, McLaughlin M. Strategies to support human oocyte development in vitro. Int J Dev Biol. 2012;56(10\u201312):901\u20137.","journal-title":"Int J Dev Biol"},{"issue":"6","key":"977_CR75","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.fertnstert.2013.03.043","volume":"99","author":"EE Telfer","year":"2013","unstructured":"Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99(6):1523\u201333.","journal-title":"Fertil Steril"},{"issue":"1","key":"977_CR76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780903382609","volume":"19","author":"NS Nagaraj","year":"2010","unstructured":"Nagaraj NS, Datta PK. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs. 2010;19(1):77\u201391.","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"977_CR77","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A. Targeting the TGF\u03b2 signalling pathway in disease. Nat Rev Drug Discov. 2012;11(10):790\u2013811.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"977_CR78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2007.09.010","volume":"108","author":"JN Bakkum-Gamez","year":"2008","unstructured":"Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, et al. M\u00fcllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Gynecol Oncol. 2008;108(1):141\u20138.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"977_CR79","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4161\/mabs.29316","volume":"6","author":"N Kersual","year":"2014","unstructured":"Kersual N, Garambois V, Chard\u00e8s T, Pouget JP, Salhi I, Bascoul-Mollevi C, et al. The human M\u00fcllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. MAbs. 2014;6(5):1314\u201326.","journal-title":"MAbs"},{"issue":"4409","key":"977_CR80","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.472712","volume":"205","author":"PK Donahoe","year":"1979","unstructured":"Donahoe PK, Swann DA, Hayashi A, Sullivan MD. M\u00fcllerian duct regression in the embryo correlated with cytotoxic activity against human ovarian cancer. Science. 1979;205(4409):913\u20135.","journal-title":"Science"},{"issue":"3","key":"977_CR81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/humupd\/dml060","volume":"13","author":"A Marca La","year":"2007","unstructured":"La Marca A, Volpe A. The anti-Mullerian hormone and ovarian cancer. Hum Reprod Update. 2007;13(3):265\u201373.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"977_CR82","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1158\/1078-0432.CCR-05-2108","volume":"12","author":"R Pieretti-Vanmarcke","year":"2006","unstructured":"Pieretti-Vanmarcke R, Donahoe PK, Szotek P, Manganaro T, Lorenzen MK, Lorenzen J, et al. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. Clin Cancer Res. 2006;12(5):1593\u20138.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"977_CR83","first-page":"3488","volume":"5","author":"PT Masiakos","year":"1999","unstructured":"Masiakos PT, MacLaughlin DT, Maheswaran S, Teixeira J, Fuller AF, Shah PC, et al. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin Cancer Res. 1999;5(11):3488\u201399.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"977_CR84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1073\/pnas.0407772101","volume":"102","author":"EJ Renaud","year":"2005","unstructured":"Renaud EJ, MacLaughlin DT, Oliva E, Rueda BR, Donahoe PK. Endometrial cancer is a receptor-mediated target for Mullerian inhibiting substance. Proc Natl Acad Sci U S A. 2005;102(1):111\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"977_CR85","first-page":"2013","volume":"40","author":"JY Song","year":"2012","unstructured":"Song JY, Jo HH, Kim MR, Lew YO, Ryu KS, Cha JH, et al. Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer. Int J Oncol. 2012;40(6):2013\u201321.","journal-title":"Int J Oncol"},{"issue":"26","key":"977_CR86","doi-asserted-by":"crossref","first-page":"15601","DOI":"10.1073\/pnas.2636900100","volume":"100","author":"TU Barbie","year":"2003","unstructured":"Barbie TU, Barbie DA, MacLaughlin DT, Maheswaran S, Donahoe PK. Mullerian inhibiting substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A. 2003;100(26):15601\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"977_CR87","doi-asserted-by":"crossref","first-page":"28371","DOI":"10.1074\/jbc.M004554200","volume":"275","author":"DL Segev","year":"2000","unstructured":"Segev DL, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, et al. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J Biol Chem. 2000;275(37):28371\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"977_CR88","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-06-2312","volume":"67","author":"V Gupta","year":"2007","unstructured":"Gupta V, Yeo G, Kawakubo H, Rangnekar V, Ramaswamy P, Hayashida T, et al. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res. 2007;67(6):2747\u201356.","journal-title":"Cancer Res"},{"issue":"7","key":"977_CR89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1134\/S0006297908070080","volume":"73","author":"AV Rodina","year":"2008","unstructured":"Rodina AV, Gukasova NV, Makarov VA, Kondrasheva IG, Khomyakova AV, Posypanova GA, et al. Localization of Mullerian inhibiting substance receptors in various human cancer cell lines. Biochem Mosc. 2008;73(7):797\u2013805.","journal-title":"Biochem Mosc"},{"issue":"10","key":"977_CR90","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2005-0480","volume":"20","author":"TT Tran","year":"2006","unstructured":"Tran TT, Segev DL, Gupta V, Kawakubo H, Yeo G, Donahoe PK, et al. Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Mol Endocrinol. 2006;20(10):2382\u201391.","journal-title":"Mol Endocrinol"},{"issue":"5","key":"977_CR91","first-page":"1182","volume":"52","author":"RL Parry","year":"1992","unstructured":"Parry RL, Chin TW, Epstein J, Hudson PL, Powell DM, Donahoe PK. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Res. 1992;52(5):1182\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"977_CR92","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/1046-5928(92)90020-W","volume":"3","author":"RC Ragin","year":"1992","unstructured":"Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT. Human m\u00fcllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. Protein Expr Purif. 1992;3(3):236\u201345.","journal-title":"Protein Expr Purif"},{"issue":"1","key":"977_CR93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-4347(01)00436-4","volume":"766","author":"HK Lorenzo","year":"2002","unstructured":"Lorenzo HK, Teixeira J, Pahlavan N, Laurich VM, Donahoe PK, MacLaughlin DT. New approaches for high-yield purification of M\u00fcllerian inhibiting substance improve its bioactivity. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;766(1):89\u201398.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"977_CR94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pep.2009.09.004","volume":"70","author":"TD Papakostas","year":"2010","unstructured":"Papakostas TD, Pieretti-Vanmarcke R, Nicolaou F, Thanos A, Trichonas G, Koufomichali X, et al. Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian inhibiting substance. Protein Expr Purif. 2010;70(1):32\u20138.","journal-title":"Protein Expr Purif"},{"key":"977_CR95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2859-8-17","volume":"8","author":"N Ferrer-Miralles","year":"2009","unstructured":"Ferrer-Miralles N, Domingo-Esp\u00edn J, Corchero JL, V\u00e1zquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Factories. 2009;8:17.","journal-title":"Microb Cell Factories"},{"issue":"10","key":"977_CR96","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrg1177","volume":"4","author":"JK Ma","year":"2003","unstructured":"Ma JK, Drake PM, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet. 2003;4(10):794\u2013805.","journal-title":"Nat Rev Genet"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-017-0977-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-0977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-0977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T13:03:12Z","timestamp":1602334992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-017-0977-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1007\/s10815-017-0977-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}